The physiological and anatomical barriers are major obstacles in the field of ocular drug delivery systems. The barriers involve nasolacrimal drainage, blinking, cornea, sclera, and blood-aqueous barriers whereas dynamic barriers involve conjunctival blood flow, lymphatic clearance and tear drainage. These barriers are showing natural protective functions, as well as limiting drug entry into the eye. Nanocarriers have been found to be effective at overcoming the problems and associated with conventional ophthalmic dosage forms. In this chapter emphasizes overcome to barriers and discusses advanced novel techniques used in the field of ocular drug delivery systems including nano dispersion systems, nanomicelles, lipidic nanocarriers, polymer...
Ocular drug delivery is a very challenging area for ophthalmologists and drug delivery scientists du...
Ocular drug delivery has been a major challenge for clinical pharmacologists and biomaterial scienti...
Ocular drug delivery has been a major challenge for clinical pharmacologists and biomaterial scienti...
Drug instillation via a topical route is preferred since it is desirable and convenient due to the n...
The eye is the most distinctive organ in the human body. Various drug delivery methods are utilised ...
Ocular drug delivery is challenging due to the presence of anatomical and physiological barriers. Th...
Ocular diseases include various anterior and posterior segment diseases. Due to the unique anatomy a...
The eye is a complex organ consisting of several protective barriers and particular defense mechanis...
The field of ophthalmic drug delivery has witnessed significant advancements through the integration...
The major challenge faced by today’s pharmacologist and formulation scientist is ocular drug deliver...
Efficient ocular drug delivery remains a challenge for pharmaceutical scientists, due to anatomical ...
Ocular drug transport barriers pose a challenge for drug delivery comprising the ocular surface epit...
The ocular drug delivery deviates through a number of anatomical and physiological barriers, which h...
Miki Honda,1 Tomohiro Asai,2 Naoto Oku,2 Yoshihiko Araki,3 Minoru Tanaka,1 Nobuyuki Ebihara11Departm...
Ocular drug delivery is a very challenging area for ophthalmologists and drug delivery scientists du...
Ocular drug delivery is a very challenging area for ophthalmologists and drug delivery scientists du...
Ocular drug delivery has been a major challenge for clinical pharmacologists and biomaterial scienti...
Ocular drug delivery has been a major challenge for clinical pharmacologists and biomaterial scienti...
Drug instillation via a topical route is preferred since it is desirable and convenient due to the n...
The eye is the most distinctive organ in the human body. Various drug delivery methods are utilised ...
Ocular drug delivery is challenging due to the presence of anatomical and physiological barriers. Th...
Ocular diseases include various anterior and posterior segment diseases. Due to the unique anatomy a...
The eye is a complex organ consisting of several protective barriers and particular defense mechanis...
The field of ophthalmic drug delivery has witnessed significant advancements through the integration...
The major challenge faced by today’s pharmacologist and formulation scientist is ocular drug deliver...
Efficient ocular drug delivery remains a challenge for pharmaceutical scientists, due to anatomical ...
Ocular drug transport barriers pose a challenge for drug delivery comprising the ocular surface epit...
The ocular drug delivery deviates through a number of anatomical and physiological barriers, which h...
Miki Honda,1 Tomohiro Asai,2 Naoto Oku,2 Yoshihiko Araki,3 Minoru Tanaka,1 Nobuyuki Ebihara11Departm...
Ocular drug delivery is a very challenging area for ophthalmologists and drug delivery scientists du...
Ocular drug delivery is a very challenging area for ophthalmologists and drug delivery scientists du...
Ocular drug delivery has been a major challenge for clinical pharmacologists and biomaterial scienti...
Ocular drug delivery has been a major challenge for clinical pharmacologists and biomaterial scienti...